Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1840]
News [4199]
Articles [378]
Editorials [10]
Conferences [103]
elearning [29]
New drug combination shows promise for breaking breast cancer resistance
New drug combination shows promise for breaking breast cancer resistance
Scientists decipher key steps in cancer development to improve treatment
Scientists decipher key steps in cancer development to improve treatment
AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations
AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations
AACR 2015: Olaparib–carboplatin combination showed early signs of clinical activity against ovarian and triple-negative breast cancers
AACR 2015: Olaparib–carboplatin combination showed early signs of clinical activity against ovarian and triple...
AACR 2015: Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer subtypes
AACR 2015: Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer...
AACR 2015: Black women found to have denser breast tissue than white women
AACR 2015: Black women found to have denser breast tissue than white women
AACR 2015: Antibody-drug conjugate shows early promise for patients with metastatic HER2-positive breast cancer
AACR 2015: Antibody-drug conjugate shows early promise for patients with metastatic HER2-positive breast cancer
AACR 2015: Adding PI3K inhibitor BYL719 to letrozole was safe, with early signs of activity against metastatic ER-positive breast cancer
AACR 2015: Adding PI3K inhibitor BYL719 to letrozole was safe, with early signs of activity against metastatic ER...
AACR 2015: Dual mTOR inhibitor-fulvestrant combo feasible, with clinical benefit for advanced breast cancer patients
AACR 2015: Dual mTOR inhibitor-fulvestrant combo feasible, with clinical benefit for advanced breast cancer...
AACR 2015: Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive breast cancer
AACR 2015: Investigational ER degrader safe, with early signs of antitumour activity against advanced ER-positive...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation